Digital & Technology
EDPB & EDPS on harmonising clinical trials
The European Data Protection Board (EDPB) and the European Data Protection Supervisor (EDPS) have expressed their support for harmonising clinical trials under the European Biotech Act. While supporting the overall goal, they emphasized the need for specific safeguards to protect sensitive health data. The regulators called for clear rules on consent, data minimization, and purpose limitation to ensure compliance with data protection principles. The EDPB and EDPS's opinion highlights the importance of balancing innovation with fundamental rights.
Data protection watchdogs call for safeguards in harmonizing clinical trials.